EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia

Xin Jiao, Zengguang Wang, Hanwen Chang, Yongjin Li, Binbin Wang, Xinfa Shao, Yuxin Zhang, Yixuan Lin, Xinlin Jia, Xianhao Zhou, Wentao Li, Dinghao Luo und 5 weitere

Journal of Cachexia, Sarcopenia and Muscle · 2026

DOI: 10.1002/jcsm.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2026. Verfasst von Xin Jiao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Orthopedic Implant, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University Scho…. Hauptthemen laut MEDLINE: Sarcopenia, Annexin A2, Muscle, Skeletal, Cerebellum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Clinical Research Program of the 9th People's Hospital, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia is a prevalent age‐related disorder characterized by progressive muscle atrophy. Impaired balance is one of its most critical clinical consequences, often leading to falling and even bone fractures. As the cerebellum plays a central role in regulating motor coordination, elucidating the molecular mechanisms underlying imbalance in sarcopenia, particularly those mediated by the muscle–cerebellum axis, remains an important yet unresolved question.

Methods

4D label‐free proteomics was employed to identify the key secretory protein mediating the interaction between muscles and cerebellums in young and aged mice. Annexin A2 (ANXA2), the candidate protein, was subsequently overexpressed using adeno‐associated virus (AAV), and its effects on both muscle and cerebellum were systematically examined. RNA‐sequencing was conducted to elucidate the molecular mechanisms underlying ANXA2 function in muscle, while stereotactic injection was performed to investigate its impact on cerebellum and related mechanisms. Finally, we evaluated the therapeutic potential of isoliquiritigenin, an inhibitor of ANXA2, in improving motor coordination and muscle function in aged mice.

Results

Aged mice showed obviously impaired motor coordination in the accelerated rotarod (AR) test ( p < 0.01) and reduced strength performance in the grip strength assay ( p < 0.05) compared to young mice. Proteomic analysis identified ANXA2 as a secretory protein predominantly produced by aged skeletal muscles ( p < 0.05 in tibialis anterior, gastrocnemius muscle and quadriceps femoris) but not by other aged organs such as heart, liver, kidney, spleen and lung (all p > 0.05). Functionally, ANXA2 exacerbated muscle atrophy by upregulating atrophy‐related markers MuRF‐1 and Atrogin‐1 (both p < 0.05) and reducing the myotube diameter via regulation of Neuraminidase 2 (Neu2) ( p < 0.05). Moreover, ANXA2 was transported into the cerebellum through the blood stream and targeted type 2 cannabinoid receptors (CB2R) in cerebellar Purkinje cells (PCs) of lobule IV/V, thereby contributing to motor incoordination as evidenced by impaired performance in AR tests ( p < 0.05). Importantly, isoliquiritigenin, an extract from licorice, effectively inhibited ANXA2 expression in muscle ( p < 0.05), alleviated muscle atrophy ( p < 0.05) and motor incoordination ( p < 0.05), while showing no adverse effects on anxiety‐like behaviours associated with CB2R ( p > 0.05).

Conclusions

ANXA2 is a key mediator of the muscle–cerebellum axis in sarcopenia, contributing to muscle atrophy by downregulating Neu2 and motor incoordination by targeting CB2R. Isoliquiritigenin was identified as an effective compound targeting ANXA2 to improve motor deficits. These findings highlight ANXA2 as a potential therapeutic target and suggest isoliquiritigenin as a promising strategy for alleviating motor incoordination associated with sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaAnnexin A2Muscle, SkeletalCerebellumAnimalsMiceMaleProteomicsHumansDisease Models, Animal

Stichwörter der Autor:innen

ANXA2Purkinje cellsisoliquiritigeninmotor coordinationmuscle–cerebellum axissarcopenia

Substanzen

Annexin A2

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Orthopedic Implant, Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical…
  • Engineering Research Center of Digital Medicine and Clinical Translation, School of Biomedical Engineering & Med-X Research Institute, Ministry of Education, Shanghai Jiao Tong University, Shanghai, China.
  • Neuroscience and Neuroengineering Center, Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Oral Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical R…
  • Department of Sports Medicine, Institute of Sports Medicine of Peking University, Beijing Key Laboratory of Sports Injuries, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Dongyun Gu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Clinical Research Program of the 9th People's Hospital, Shanghai Jiao Tong University School of Medicine
  • Shanghai Key Laboratory of Orthopedic Implants

Zitieren

APA

Jiao, X., Wang, Z., Chang, H., Li, Y., Wang, B., Shao, X., Zhang, Y., Lin, Y., Jia, X., Zhou, X., Li, W., Luo, D., Deng, T., Lin, X., Xu, C., Gan, Y., & Gu, D. (2026). Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70203

Vancouver

Jiao X, Wang Z, Chang H, Li Y, Wang B, Shao X, et al. Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia. Journal of Cachexia, Sarcopenia and Muscle. 2026. doi:10.1002/jcsm.70203

BibTeX
@article{Jiao2026,
  author = {Jiao, Xin and Wang, Zengguang and Chang, Hanwen and Li, Yongjin and Wang, Binbin and Shao, Xinfa and Zhang, Yuxin and Lin, Yixuan and Jia, Xinlin and Zhou, Xianhao and Li, Wentao and Luo, Dinghao and Deng, Tanjun and Lin, Xingzuan and Xu, Chen and Gan, Yaokai and Gu, Dongyun},
  title = {Annexin A2 Causes Motor Incoordination via Muscle–Cerebellum Axis in Sarcopenia},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2026},
  doi = {10.1002/jcsm.70203}
}
Kostenlos starten →